Cleared Traditional

K974701 - ORGENTEC ANTI-MPO (P-ANCA) ELISA

K974701 is the FDA 510(k) clearance for ORGENTEC ANTI-MPO (P-ANCA) ELISA by American Laboratory Products Co., Ltd.. It is a Class 2 Immunology device (product code MOB) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1998
Decision
71d
Days
Class 2
Risk

K974701 is an FDA 510(k) clearance for the ORGENTEC ANTI-MPO (P-ANCA) ELISA. Classified as Test System, Antineutrophil Cytoplasmic Antibodies (anca) (product code MOB), Class II - Special Controls.

Submitted by American Laboratory Products Co., Ltd. (Windham, US). The FDA issued a Cleared decision on February 17, 1998 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Laboratory Products Co., Ltd. devices

Submission Details

510(k) Number K974701 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 08, 1997
Decision Date February 17, 1998
Days to Decision 71 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 104d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)

All 39
Devices cleared under the same product code (MOB) and FDA review panel - the closest regulatory comparables to K974701.
BINDAZYME ANTI-MPO ENZYME IMMUNOASSAY KIT
K981030 · The Binding Site, Ltd. · Jul 1998
QUANTA LITE PR3 IGG (SERINE PROTEASE) TEST KIT
K981328 · Inova Diagnostics, Inc. · Jun 1998
QUANTA LITE MPO IGG (MYELOPEROXIDASE) TEST KIT
K981330 · Inova Diagnostics, Inc. · Jun 1998
ORGENTEC ANTI-PR3 (C-ANCA) ELISA
K974702 · American Laboratory Products Co., Ltd. · Feb 1998
IMMUNO CONCEPTS ANCA TEST SYSTEM
K974463 · Immuno Concepts, Inc. · Feb 1998
IMMUNO CONCEPTS ANCA TEST SYSTEMS
K974478 · Immuno Concepts, Inc. · Feb 1998